Fosaprepitant SPC
Fosaprepitant SPC is indicated for the prevention of nausea and vomiting in patients receiving highly and moderately emetogenic cancer chemotherapy in adult as well as paediatric patients aged 6 months or older.
Strength:
150 mg
Dosage Form:
Vial for injection
Active ingredient:
Fosaprepitant.
Methotrexate SPC
Methotrexate SPC can be used to treat Rheumatoid arthritis, sever and uncontrolled Psoriasis and a wide range of tumors, in particular:
Strength:
2.5 mg
Dosage Form:
Tablet
Active ingredient:
Methotrexate.
Colistimethate SPC
Colistimethate SPC is indicated for the treatment of serious infections caused by selected aerobic Gram-negative pathogens in patients with limited treatment options.
Strength:
1 million IU
Dosage Form:
Vial for injection
Active ingredient:
Colistimethate Sodium
.
Renapat
Renapat is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis, peritoneal dialysis or suffering from chronic kidney disease (CKD).
Strength:
800 mg
Dosage Form:
Film-Coated Tablets
Active ingredient:
Sevelamer Carbonate.
Zoledronic Acid SPC
Zoledronic Acid SPC is indicated in adults for the treatment of Osteoporosis.
Strength:
5 mg/ 100 ml
Dosage Form:
Vial for injection
Active ingredient:
Zoledronic Acid Monohydrate.
Surlex
Surlex is indicated for the reversal of neuromuscular blockade induced by specific muscle relaxants (rocuronium or vecuronium) in adults as well as paediatrics aged from 2-17 years old.
Strength:
100 mg
Dosage Form:
Vial for injection
Active ingredient:
Sugammadex.
